Antibody induction therapy for lung transplant recipients

Author:

Penninga Luit1,Møller Christian H2,Penninga Elisabeth I3,Iversen Martin4,Gluud Christian5,Steinbrüchel Daniel A2

Affiliation:

1. Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Copenhagen Denmark DK-2100

2. Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery, RT 2152; Blegdamsvej 9 Copenhagen Denmark DK-2100

3. Bispebjerg Hospital; Department of Clinical Pharmacology; Bispebjerg Bakke 23 Copenhagen Denmark DK-2400

4. Rigshospitalet, Copenhagen University Hospital; Medical Department B-2142, Division of Lung Transplantation; Blegdamsvej 9 Copenhagen Denmark DK-2100

5. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Reference66 articles.

1. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab;Brock;Journal of Heart & Lung Transplantation,2001

2. Antilymphocyte globulin (ALG) vs. placebo in immunosuppression in lung transplant [abstract];Chaparro;Journal of Heart & Lung Transplantation,1999

3. Conte JV The use of daclizumab and anti-thymocyte globulin in lung transplantation www.clinicaltrials.gov/ct2/show/NCT00181142

4. Rabbit anti-thymocyte globulin induction therapy does not prolong survival after lung transplantation;Hartwig;Journal of Heart & Lung Transplantation,2008

5. Rabbit antithymocyte globulin induction therapy for lung transplantation does not affect long-term allograft function or survival [abstract];Hartwig;Journal of Heart & Lung Transplantation,2005

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3